(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 208.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.
Mira Pharmaceuticals's earnings in 2025 is -$7,852,659.On average, 1 Wall Street analyst forecast MIRA's earnings for 2025 to be -$9,079,373, with the lowest MIRA earnings forecast at -$9,079,373, and the highest MIRA earnings forecast at -$9,079,373.
In 2026, MIRA is forecast to generate -$8,911,237 in earnings, with the lowest earnings forecast at -$8,911,237 and the highest earnings forecast at -$8,911,237.